Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
PM beats second-quarter estimates as adjusted EPS rose 15.2% and organic sales climbed 7.6%, while smoke-free growth supported results.
Philip Morris International (PM) reported better-than-expected results in the previous three-month p
While the top- and bottom-line numbers for Philip Morris (PM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Strong quarterly results overshadowed by softer third-quarter outlookPhilip Morris International Inc. (NYSE:PM) reported better-than-expected second-quarter 2026 results on Wednesday, but investors focused on weaker-than-anticipated third-quarter earnings guidance, sending the stock modestly lower.
Philip Morris International reports better-than-expected second-quarter earnings but lowers full-year profit expectations.
Philip Morris (PM) delivered earnings and revenue surprises of +7.84% and +6.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Investing.com -- Philip Morris International Inc. (NYSE: PM) reported second-quarter earnings and revenue that topped consensus expectations on Wednesday, however, shares have edged lower after the company's Q3 earnings guidance missed the consensus estimate.
Philip Morris International recorded higher revenue in the second quarter, boosted by growth in its international business and its Zyn portfolio in the U.S.
Tobacco company Philip Morris International (NYSE:PM) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.4% year on year to $11.19 billion. Its GAAP profit of $1.80 per share was 9% below analysts’ consensus estimates.
Philip Morris International Inc‘s (NYSE:PM) investors may be eyeing potential gains from the tobacco company’s dividends ahead of its second-quarter earnings report on Wednesday, July 22. Analysts expect quarterly earnings of $2.05 per share, up from $1.91 per share in...
July 22 (Reuters) - U.S. stock index futures dipped on Wednesday, pressured by weakness in chip stocks, as investors remained cautious ahead of the first batch of Big Tech earnings that could decide
↗️ Super Micro Computer (SMCI): Shares surged in premarket trading after the AI server maker projected fourth-quarter gross margins roughly double those it had originally targeted. Rivals Dell Technologies (DELL) and Hewlett Packard Enterprises (HPE) also rallied.
Today Earnings: AT&T, GE Vernova, PulteGroup, CME Group, Moody’s, Philip Morris International Earnings (p.m.): Alphabet, Tesla, IBM, Southwest Airlines, Texas Instruments, CSX, ServiceNow, Raymond James Economic data: The Energy Information Administration will release its weekly petroleum status report.
Tobacco company Philip Morris International (NYSE:PM) will be reporting results this Wednesday before market open. Here’s what to look for.
Today Earnings (a.m.): General Motors, Charles Schwab, Danaher, 3M, Equifax, Hasbro, Northrop Grumman, Halliburton Earnings (p.m.): Chubb, Capital One, Interactive Brokers Economic data: ADP weekly ...
Today Earnings (a.m.): Domino’s Pizza, AMC Entertainment Holdings Earnings (p.m.): Steel Dynamics Economic data: U.S. leading economic indicators report for June Tomorrow Earnings: General Motors, ...
It’s a heavy earnings week, with results also coming in from Halliburton, 3M, AT&T, Blackstone, and more. On the economic front, we’ll see data on jobs, new-home sales, and industry purchasing activity.
Earlier this week, Philip Morris International announced that the U.S. FDA had authorized commercialization of its ZYN smoke-free nicotine pouches as modified risk tobacco products, recognizing that switching completely from cigarettes to ZYN reduces exposure to harmful chemicals linked to major smoking-related diseases. This decision makes ZYN the first and only nicotine pouch brand with modified risk status in the U.S., giving Philip Morris a distinct regulatory and scientific edge in the...